---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-189169"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:45:53.254395+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma stockholders approve reverse stock split, equity plan amendment; files $119.7M ATM prospectus

## Summary
- Stockholders approved reverse stock split in range 1-for-5 to 1-for-30; board to determine ratio.
- Approved amendment to 2021 equity plan to add 25M shares and reduce annual evergreen from 5% to 4%.
- Approved issuance of common stock underlying outstanding warrants for Nasdaq Listing Rule 5635(d) compliance.
- Filed prospectus supplement to register up to $119.7M of common stock for ATM offering through Stifel.

## SEC filing metadata
- accession: 0001193125-25-189169
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/0001193125-25-189169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/d24419d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-189169
- JSON: https://secwatch.observer/filing/0001193125-25-189169.json
- Plain text: https://secwatch.observer/filing/0001193125-25-189169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.